In a move that’s sure to grab the attention of horticulturalists, plant health regulators, and UK exporters, the European Food Safety Authority (EFSA) has set out its findings on the risks posed by certain Lonicera (honeysuckle) plants imported from the UK. Published on January 7, 2026, the study promises to affect plant trade and biosecurity measures, stirring debate between trade facilitators and strict plant health advocates.
This new development comes as part of EFSA’s scientific opinion—a category of document aimed at providing expert assessment rather than binding legislation. The underlying report was prepared by EFSA’s Plant Health Panel, the dedicated body tasked with evaluating plant-related risks within the institution.
Unlike new laws, EFSA’s opinions serve as scientific advice intended to guide regulators but do not enforce mandatory changes. This particular opinion evaluates commodity risk relating to three Lonicera varieties: Lonicera ligustrina var. pileata, Lonicera ligustrina var. yunnanensis, and Lonicera periclymenum, imported from the UK. While the document does not impose concrete policy targets or deadlines, it highlights potential vulnerabilities that should inform regulatory oversight.
The risk assessment signals a careful balancing act between increasing plant health protection measures in the EU and maintaining smooth import channels with an important trading partner, the UK. The panel’s findings may push for tighter supervision and possibly new requirements on these plant imports, potentially raising operational costs and administrative tasks for UK nurseries exporting these varieties.
Stakeholders most affected by this EFSA opinion include UK plant producers facing stricter scrutiny and possible additional hygiene or pest control measures; EU plant health authorities who would need to strengthen inspection regimes; consumers and gardeners who rely on the availability of these honeysuckle varieties; and EU environmental NGOs focused on biodiversity and invasive species management.
Looking ahead, while EFSA’s opinion launches a fresh insight into the risk, it is likely to prompt further regulatory reviews and possibly proposals from the European Commission. National authorities in member states will play a key role in interpreting and implementing any adjusted phytosanitary policies. Thus, this opinion kick-starts a process of heightened attention rather than closing an issue.
In sum, EFSA’s January 2026 scientific opinion on Lonicera plants from the UK underscores an ongoing negotiation between trade facilitation and biosecurity risk management within EU plant health governance.
← Atlas › News › Agri-Food